These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17095227)

  • 1. Design and synthesis of phenethyl benzo[1,4]oxazine-3-ones as potent inhibitors of PI3Kinasegamma.
    Lanni TB; Greene KL; Kolz CN; Para KS; Visnick M; Mobley JL; Dudley DT; Baginski TJ; Liimatta MB
    Bioorg Med Chem Lett; 2007 Feb; 17(3):756-60. PubMed ID: 17095227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing.
    Hirsch E; Lembo G; Montrucchio G; Rommel C; Costa C; Barberis L
    Thromb Haemost; 2006 Jan; 95(1):29-35. PubMed ID: 16543958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
    Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Barberis L; Hirsch E
    Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
    Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
    J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase.
    Gütschow M; Neumann U
    J Med Chem; 1998 May; 41(10):1729-40. PubMed ID: 9572899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors.
    Payne RJ; Peyrot F; Kerbarh O; Abell AD; Abell C
    ChemMedChem; 2007 Jul; 2(7):1015-29. PubMed ID: 17487900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
    Zhao JJ; Roberts TM
    Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of tricyclic 1,3-oxazin-4-ones and kinetic analysis of cholesterol esterase and acetylcholinesterase inhibition.
    Pietsch M; Gütschow M
    J Med Chem; 2005 Dec; 48(26):8270-88. PubMed ID: 16366609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors.
    Dixit M; Tripathi BK; Tamrakar AK; Srivastava AK; Kumar B; Goel A
    Bioorg Med Chem; 2007 Jan; 15(2):727-34. PubMed ID: 17095232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoinositide 3-kinase gamma inhibition plays a crucial role in early steps of inflammation by blocking neutrophil recruitment.
    Ferrandi C; Ardissone V; Ferro P; Rückle T; Zaratin P; Ammannati E; Hauben E; Rommel C; Cirillo R
    J Pharmacol Exp Ther; 2007 Sep; 322(3):923-30. PubMed ID: 17526805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative feedback regulation of Rac in leukocytes from mice expressing a constitutively active phosphatidylinositol 3-kinase gamma.
    Costa C; Barberis L; Ambrogio C; Manazza AD; Patrucco E; Azzolino O; Neilsen PO; Ciraolo E; Altruda F; Prestwich GD; Chiarle R; Wymann M; Ridley A; Hirsch E
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14354-9. PubMed ID: 17720808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting inflammation in rheumatoid arthritis.
    Firestein GS
    N Engl J Med; 2006 Jan; 354(1):80-2. PubMed ID: 16394307
    [No Abstract]   [Full Text] [Related]  

  • 14. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2.
    Ferrali A; Menchi G; Occhiato EG; Danza G; Mancina R; Serio M; Guarna A
    Bioorg Med Chem Lett; 2005 Jan; 15(1):145-8. PubMed ID: 15582428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel analogues of archazolid: a highly potent simplified V-ATPase inhibitor.
    Menche D; Hassfeld J; Sasse F; Huss M; Wieczorek H
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1732-5. PubMed ID: 17239591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PI3Kgamma differentially regulates FcepsilonRI-mediated degranulation and migration of mast cells by and toward antigen.
    Endo D; Gon Y; Nunomura S; Yamashita K; Hashimoto S; Ra C
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():66-72. PubMed ID: 19494508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.
    Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P
    Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.